Leonard G. Gomella, MD, discusses the factors that determine which patients with prostate cancer should undergo genetic testing.
Leonard G. Gomella, MD
Advertisement
Articles by Leonard G. Gomella, MD
The 12 month countdown to the adoption of ICD-10 has begun.
Leonard G. Gomella, MD, from the Kimmel Cancer Center, discusses the utilization of circulating tumor cells in patients with solid tumors.
Advertisement
Latest Updated Articles
Considering Genetic Testing in Patients With Prostate CancerPublished: November 6th 2019 | Updated:
ICD-10 and Urologic Oncology: A Disappointing CombinationPublished: September 22nd 2014 | Updated:
Utilizing CTCs in Solid TumorsPublished: May 10th 2013 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
